SCHEMBL4586485

SCHEMBL4586485

C=Cc1ccc2ncc(C)nc2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TGFBR1 P36897 2/20 0.39
▸ TP53 P04637 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ ALDH1A1 P00352 2/20 0.34
▸ CCNB2 O95067 1/20 0.34
▸ CDK1 P06493 1/20 0.34
▸ CCNB1 P14635 1/20 0.34
▸ CDK5 Q00535 1/20 0.34
▸ CDK5R1 Q15078 1/20 0.34
▸ CCNB3 Q8WWL7 1/20 0.34
▸ IRAK4 Q9NWZ3 1/20 0.34
▸ TYMS P04818 1/20 0.33
▸ TRPA1 O75762 1/20 0.33
▸ CYP1A2 P05177 2/20 0.32
▸ SRC P12931 1/20 0.32
▸ KDR P35968 3/20 0.31
▸ FGFR3 P22607 2/20 0.31
▸ NPC1 O15118 1/20 0.31
▸ PDGFRB P09619 1/20 0.31
▸ FLT3 P36888 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14829741 0.82 TGFBR1 (0.42) TGFBR1TDP1ALDH1A1CCNB2CDK1
SCHEMBL4586234 0.79 ALDH1A1 (0.47) TGFBR1ALDH1A1TYMSSRCKDR
SCHEMBL28596237 0.75 KDM4E (0.38) TGFBR1TDP1ALDH1A1CCNB2CDK1
SCHEMBL16289900 0.75 CYP1A2 (0.52) TP53TDP1ALDH1A1TYMSTRPA1
SCHEMBL8344116 0.75 CYP1A2 (0.54) TDP1ALDH1A1CCNB2CDK1CCNB1
SCHEMBL30578800 0.75 CYP1A2 (0.54) TDP1ALDH1A1CCNB2CDK1CCNB1
SCHEMBL29639029 0.75 CYP1A2 (0.54) TDP1ALDH1A1CCNB2CDK1CCNB1
SCHEMBL16289772 0.74 CYP1A2 (0.57) TP53TDP1ALDH1A1TYMSCYP1A2
SCHEMBL3274768 0.72 NPC1 (0.45) TGFBR1TP53TDP1ALDH1A1TYMS
SCHEMBL5049992 0.72 ATM (0.40) NPC1RAB9ASMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080214455-A1 Novel Chemical Compounds SMITHKLINE BEECHAM CORPORATION 2008-09-04 — — US disclosed
EP-1879563-A4 NOVEL CHEMICAL COMPOUNDS SMITHKLINE BEECHAM CORP (US) 2008-07-16 — — EP disclosed
EP-1879563-A2 NOVEL CHEMICAL COMPOUNDS Smithkline Beecham Corporation (US) 2008-01-23 — — EP disclosed
WO-2006132739-A2 NOVEL CHEMICAL COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 2006-12-14 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080214455-A1 Novel Chemical Compounds HIPK3, HIPK1, HIPK4 TGFBR1 4319/4885TP53 2984/4885TDP1 690/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback